PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sentinel Public Relations (P) Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Elder Pharmaceuticals Sets Up Elvista – A Division Dedicated To Tap Rural Markets - Elvista Set Up with a dedicated sales force of 240 - to go up to 750 by FY 2012
Elder Pharmaceuticals Sets Up Elvista – A Division Dedicated To Tap Rural Markets

 

NewswireToday - /newswire/ - Mumbai, Maharashatra, India, 2009/07/20 - Elvista Set Up with a dedicated sales force of 240 - to go up to 750 by FY 2012.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The Rs 650 crore Elder Pharmaceuticals Limited (NSE – ELDERPHARM) has set up a dedicated division called “Elvista” to spread its network to villages, towns, sub-urban/periphery markets and hinterland districts. Initial target is Class II to IV towns and rural markets with a dedicated sales force of 240. “We plan to increase Elvista’s marketing strength to about 750 personnel or “product specialists” by 2012”, says Alok Saxena, Director, Elder Pharma. The company has earmarked an investment of Rs 40 crore for its rural thrust.

Elvista is targeting therapeutic categories which have greater relevance in rural areas and are preferred by doctors like Anti-peptic Ulcerants, Anti-Malarials, Anti-infectives, NSAIDS, Quinolones, Cough preparations, etc. The division has been launched with the support of 16 brands which included a big brand like Eldervit injection. And few niche brands like Mucodyne, Mucobron, Protocream and Venex too have been launched in these towns.

Elvista has already penetrated the rural markets of UP, Maharashtra, Andhra and Bihar and soon will enter the South. Before Dec 2012, Elvista plans to reach 1500 villages with populations of below 40,000, 300 villages with populations of 40,000 to 100,000 and over 75 peripheral villages/towns around MMR (Mumbai Metropolitan region). By 2012, Elvista’s target is to cover about five lakh doctors promoting health education and awareness.

Adds Saxena, “Rural markets offer large potential volume growth which has not been tapped properly by most of the pharmaceutical companies. Rising rural income levels, sops by government to set up health infrastructure in rural areas, thrust on rural health programmes, emergence of lifestyle diseases and penetration of medical insurance are fuelling pharma growth in rural areas.”

Although more than 60% of Indian populace lives in rural areas, it accounts for a meager 21% of the total pharmaceuticals market. By 2015 rural pharma market will be around 27% out of the total estimated pharmaceuticals sector size of Rs 90,000 crore.

Elder has over 350 products with focus of generics, women’s healthcare, pain management lifestyle diseases etc which are planned to be taken to the rural markets by 2012 by which time Elvista is expected to contribute about 15 percent of Elder’s total turnover.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sentinel Public Relations (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Elder Pharmaceuticals Sets Up Elvista – A Division Dedicated To Tap Rural Markets

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Mitesh M Kapadia - PublicRelationIndia.com 
+91 22 28625131 mitesh[.]publicrelationindia.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sentinel Public Relations (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sentinel Public Relations (P) Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)